Cim, LLC Fulgent Genetics, Inc. Transaction History

Cim, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$47.98 - $62.75 $1,535 - $2,008	-32 Reduced 0.58%	5,518 $325,000
Q1 2022 Apr 12, 2022	BUY	$49.85 - $96.11 $11,864 - $22,874	238 Added 4.48%	5,550 $319,000
Q4 2021 Jan 26, 2022	BUY	$77.3 - $105.0 $40,350 - $54,810	522 Added 10.9%	5,312 $337,000
Q3 2021 Nov 08, 2021	BUY	$74.87 - $110.87 $101,598 - $150,450	1,357 Added 39.53%	4,790 $370,000
Q2 2021 Aug 09, 2021	BUY	$66.8 - $100.45 $229,324 - $344,844	3,433 New	3,433 $363,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

Stay updated on Cim, LLC with notifications on news.